Assessment of Response to Therapy for Bone Metastases: Is it Still a Challenge in Oncology?
Authors:
- 31 July 2010
- journal article
- review article
- Published by Elsevier in PET Clinics
- Vol. 5 (3) , 311-326
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancerBritish Journal of Cancer, 2010
- Imaging metastatic bone disease from carcinoma of the prostateBritish Journal of Cancer, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Advancing Treatment for Metastatic Bone Cancer: Consensus Recommendations from the Second Cambridge ConferenceClinical Cancer Research, 2008
- Prostate-specific antigen induces apoptosis of osteoclast precursors: Potential Role in osteoblastic bone metastases of prostate cancerThe Prostate, 2006
- Bone Imaging in Metastatic Breast CancerJournal of Clinical Oncology, 2004
- Metastasis to bone: causes, consequences and therapeutic opportunitiesNature Reviews Cancer, 2002
- Assessment of bone response to systemic therapy in an EORTC trial: preliminary experience with the use of collagen cross-link excretionBritish Journal of Cancer, 1999
- Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinomaBritish Journal of Cancer, 1996
- Assessment of response to therapy in advanced breast cancerBritish Journal of Cancer, 1977